rubida sp. nov., which have strong antibacterial activity against Gram-positive bacteria1\ The complex consists of seven components; mycinamicins I (1), II (2) , III (3), IV (4), V (5), VI (6) and VII (7)2~4). During the search for new antibiotics from the fermentation broth of mycinamicinproducing strains, we have discovered a new minor component designated mycinamicin VIII (8). Recently, the same product has been obtained in much higher yield from the fermentation ofa mutant strain C-7-1, isolated during on going mutagenic studies of M. griseorubida sp. nov. In addition, this mutant was found to accumulate protomycinolide IV (9)5). These compounds (8 and 9) are considered to be key intermediates in the biosynthesis of the mycinamicins. In this communication we describe the isolation and identification of the new metabolite, compound 8, which provided definitive information about the biosynthetic pathway from protomycinolide IV (9) to mycinamicin IV (4). were determined by analytical HPLC(compound 8, 73%; compound9, 24%; other minor components < 3%), and from these result,it seems likely that the C-7-1 strain is blocked at the step of the oxidation at the C-21 position. Compound 9 is a 16-membered lactone with the fundamental carbon skeleton of the mycinamicin aglycones, and may be the first biosynthetic intermediate. A summary of the proposed pathway from protomycinolide IV (9) to mycinamicin IV (4) is shown as Fig. 1 . According Table 2 . Antibacterial spectra of mycinamicins VIII (8) and IV (4).
MIC tog/ml) considered, one that proceeds through neutral as well as basic intermediates. If so, the relationship to tylosin biosynthesis mayrequire revision. In order to clarify this situation, bioconversion experiments are being carried out.
Mycinamicin VIII (8) exhibited antibacterial activity against Gram-positive bacteria. As shown in Table 2 , the antibacterial activities of 8 were muchless than that of4.
Experimental
General Procedure The IR spectra were taken with a Hitachi 260-50 IR spectrophotometer.
The UV spectra were recorded on a Shimadzu UV-365 spectrometer. The NMR spectra were obtain with a Jeol JNM-GSX400 spectrometer at 400 (XH) and 100 (13C) MHzwith TMSas an internal reference. The MS were taken with a Jeol JMS-SX102 spectrometer. Analytical HPLCwas carried out with a Shimadzu LC-6A system, a YMC-GELODS 5 /mi, stainless steel column (YamamuraChemical Institute, Ltd., Kyoto), 150mmx 4mmi.d. Flow rate of the mobile phase (0.1 m NaH2PO4-methanolacetonitrile, 55: 31 : 14) was 0.8ml/minute and
The mutant strain C-7-1 was isolated after A^methyl-7V'-nitro-JV-nitrosoguanidine (NTG) treatment of mycinamicin-producing strains of M. griseorubida A1 1725. Culture conditions and production media were as described previously1}.
Isolation and Purification
The culture filtrate (1 liter) of a mutant was extracted at pH9.0 with equal volumes of ethyl acetate. The mycinamicins in the organic extract were transferred to a dilute hydrochloric acid solution (pH3.0).
The acidic aqueous layer was extracted with ethyl acetate at pH9.0. The ethyl acetate phase was dried (Na2SO2) and concentrated in vacuo to a solid residue and gave a crude powder (ca. lOOmg)of the neutral component, protomycinolide IV (9). The acidic aqueous layer was extracted with ethyl acetate at pH 9.0 and this organic extract was concentrated to afford the mycinamicin VIII (8) as a crude powder (350mg). This compound 8 was purified by preparative HPLC (YMC-GEL ODS 1-25/44, 600mm x 20mmi.d.) using 0.1 m NaH2PO4 (pH2.5, adjusted with 20% H3PO4)-methanol (4: 6) as solvent system with detection at 220nm. Fractions (20ml) were collected at a flow rate of 10 ml/minute. Individual fractions were assayed by analytical HPLC. The retention time of 8 was 46.3 minutes. When the area of8 peak exceeded 95% of all other peaks in the HPLCtrace, the fractions were collected and combined, and the methanol was removed in vacuo. The aqueous solutions were extracted with ethyl acetate at pH9.0. The ethyl acetate extract was dried (Na2SO4) and concentrated in vacuo. Mycinamicin VIII (8) was crystallized from /2-hexane and acetone to afford colorless prisms. The crystals were collected by filtration, washed with «-hexane, and dried in vacuo to give 8 (260mg).
